Rhythm Pharmaceuticals buy The Goldman Sachs Group, Inc.
Start price
07.12.23
/
50%
€35.40
Target price
07.12.24
€38.96
Performance (%)
-6.78%
Price
31.05.24
€33.00
Summary
This prediction is currently active. With a performance of -6.78%, the BUY prediction for Rhythm Pharmaceuticals by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 07.12.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | -2.941% | -2.941% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $38.00 to $42.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€40.80
25.01.24
25.01.24
€47.88
25.01.25
25.01.25
-19.12%
31.05.24
31.05.24
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€23.20
02.03.23
02.03.23
€42.45
02.03.24
02.03.24
69.83%
03.03.24
03.03.24